{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T17:59:46Z","timestamp":1783187986266,"version":"3.54.6"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,9]]},"DOI":"10.7759\/cureus.108555","type":"journal-article","created":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T16:44:07Z","timestamp":1778345047000},"source":"Crossref","is-referenced-by-count":1,"title":["Progressive Asymptomatic Hyperglycemia and Glucosuria Identified Through Protocol-Driven Monitoring in a Clinical Trial: A Case Report"],"prefix":"10.7759","author":[{"given":"Raymond T","family":"Anasobi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Stumbris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2337\/dc25-S002","article-title":"2. Diagnosis and classification of diabetes: standards of care in diabetes-2025","volume":"48","year":"2025","unstructured":"2. Diagnosis and classification of diabetes. standards of care in diabetes-2025. Diabetes Care. 2025, 48:S27-49. 10.2337\/dc25-S002","journal-title":"Diabetes Care"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2337\/dc14-0984","article-title":"Hyperosmolar hyperglycemic state: a historic review of the clinical presentation, diagnosis, and treatment","volume":"37","author":"Pasquel FJ","year":"2014","unstructured":"Pasquel FJ, Umpierrez GE. Hyperosmolar hyperglycemic state: a historic review of the clinical presentation, diagnosis, and treatment. Diabetes Care. 2014, 37:3124-31. 10.2337\/dc14-0984","journal-title":"Diabetes Care"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2337\/dci20-0053","article-title":"Social determinants of health and diabetes: a scientific review","volume":"44","author":"Hill-Briggs F","year":"2020","unstructured":"Hill-Briggs F, Adler NE, Berkowitz SA, et al.. Social determinants of health and diabetes: a scientific review. Diabetes Care. 2020, 44:258-79. 10.2337\/dci20-0053","journal-title":"Diabetes Care"},{"key":"ref4","article-title":"Diabetes mellitus: management and therapies","author":"Powers AC","year":"2022","unstructured":"Powers AC, Stafford JM, Rickels MR. Diabetes mellitus: management and therapies. Harrison\u2019s Principles of Internal Medicine. Longo DL, Fauci AS, Kasper DL (ed): McGraw Hill, New York, NY; 2022."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2009.02894.x","article-title":"Role of the kidney in normal glucose homeostasis and in the hyperglycaemia of diabetes mellitus: therapeutic implications","volume":"27","author":"Gerich JE","year":"2010","unstructured":"Gerich JE. Role of the kidney in normal glucose homeostasis and in the hyperglycaemia of diabetes mellitus: therapeutic implications. Diabet Med. 2010, 27:136-42. 10.1111\/j.1464-5491.2009.02894.x","journal-title":"Diabet Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-014-0195-0","article-title":"Impact of social determinants of health on outcomes for type 2 diabetes: a systematic review","volume":"47","author":"Walker RJ","year":"2014","unstructured":"Walker RJ, Smalls BL, Campbell JA, Strom Williams JL, Egede LE. Impact of social determinants of health on outcomes for type 2 diabetes: a systematic review. Endocrine. 2014, 47:29-48. 10.1007\/s12020-014-0195-0","journal-title":"Endocrine"},{"key":"ref7","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group","volume":"352","year":"1998","unstructured":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group . Lancet. 1998, 352.837-53.","journal-title":"Lancet"},{"key":"ref8","unstructured":"U.S. Food and Drug Administration. Oversight of clinical investigations \u2014 a risk-based approach to monitoring. (2013). Accessed: April 28, 2026: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/oversight-clinical-investigations-risk-based...."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.2337\/dc25-S006","article-title":"6. Glycemic goals and hypoglycemia: standards of care in diabetes-2025","volume":"48","year":"2025","unstructured":"6. Glycemic goals and hypoglycemia. standards of care in diabetes-2025. Diabetes Care. 2025, 48:S128-45. 10.2337\/dc25-S006","journal-title":"Diabetes Care"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S106821","article-title":"Poor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributors","volume":"10","author":"Polonsky WH","year":"2016","unstructured":"Polonsky WH, Henry RR. Poor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributors. Patient Prefer Adherence. 2016, 10:1299-307. 10.2147\/PPA.S106821","journal-title":"Patient Prefer Adherence"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2337\/dc13-1165","article-title":"The relative and combined ability of high-sensitivity cardiac troponin T and N-terminal pro-B-type natriuretic peptide to predict cardiovascular events and death in patients with type 2 diabetes","volume":"37","author":"Hillis GS","year":"2014","unstructured":"Hillis GS, Welsh P, Chalmers J, et al.. The relative and combined ability of high-sensitivity cardiac troponin T and N-terminal pro-B-type natriuretic peptide to predict cardiovascular events and death in patients with type 2 diabetes. Diabetes Care. 2014, 37:295-303. 10.2337\/dc13-1165","journal-title":"Diabetes Care"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/491994-progressive-asymptomatic-hyperglycemia-and-glucosuria-identified-through-protocol-driven-monitoring-in-a-clinical-trial-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T16:44:10Z","timestamp":1778345050000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/491994-progressive-asymptomatic-hyperglycemia-and-glucosuria-identified-through-protocol-driven-monitoring-in-a-clinical-trial-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,9]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.108555","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,9]]}}}